Click here to read the articles and download the PDF

Pharmaceutical Commerce - February 2025

Leaders with top third-party logistics providers discuss the evolving landscape for the sector in 2025—and the new strides made in their quest to help transform the pharma supply chain.

3PLs: From Resilience to Sustainability

What factors should be considered—and how can both parties benefit long-term?

M&A in Pharma: Balancing Growth and Risk

How chain and local closures are impacting healthcare access.

The Prominence of Pharmacy Deserts

Articles

The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a month, while Lilly also sells the GLP-1 via its LillyDirect platform.

Hims & Hers Begins Selling Zepbound

Videos

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, lays out the basics surrounding accumulators, maximizers, and AFPs. 

Hubs East 2025: Understanding Copay Accumulators, Maximizers, and Alternative Funding Programs

The latest news for pharma industry insiders.

Pharma Pulse 4/2/25: Balancing Cost-Efficiency with Domestic Manufacturing Need, Making M3P Work for Your Pharmacy & more

CRYOPDP—centered around clinical trials, biopharma, and cell and gene therapies—augments DHL’s specialty pharma logistics expertise.

DHL Purchases Cryoport’s Specialty Courier

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, discusses the challenges that many Americans face regarding the affordability of GLP-1 drugs.

The Financial Barrier to GLP-1s

Pharma Pulse 4/1/25: Restructuring Medical Device Supply Chains, Role of Pharmacists in COVID-19 Care and Prevention & more

Jen Butler, chief commercial officer, Pleio, discusses the importance of balancing technology and personalization in patient support. 

Hubs East 2025: Balancing Technology, Personalization, and Human Connection in Patient Support

Podcasts

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments. 

Embarking on the CAR-T Journey

Pharma Pulse 3/31/25: Bridging the HCP-Patient Divide, Kennedy Proposes Massive Reorganization, Staff Cuts at HHS & more

Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support are working to evolve patient engagement strategies. 

Featured Content

Pharmaceutical Commerce - February 2025

3PLs: From Resilience to Sustainability

M&A in Pharma: Balancing Growth and Risk

The Prominence of Pharmacy Deserts